Prudential Financial Inc Deciphera Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	BUY	$37.05 - $65.03 $126,562 - $222,142	3,416 New	3,416 $204,000
Q1 2020 May 12, 2020	SELL	$33.63 - $69.4 $2,185 - $4,511	-65 Closed	0 $0
Q4 2019 Aug 05, 2021	SELL	$31.7 - $69.93 $159,292 - $351,398	-5,025 Reduced 98.72%	65 $4,000
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $161,353 - $355,943	5,090 New	5,090 $316,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.